These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22761741)

  • 21. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood trauma and platelet brain-derived neurotrophic factor (BDNF) after a three month follow-up in patients with major depressive disorder.
    Jeon HJ; Kang ES; Lee EH; Jeong EG; Jeon JR; Mischoulon D; Lee D
    J Psychiatr Res; 2012 Jul; 46(7):966-72. PubMed ID: 22551661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
    Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
    World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
    [No Abstract]   [Full Text] [Related]  

  • 25. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
    Yoshida T; Ishikawa M; Niitsu T; Nakazato M; Watanabe H; Shiraishi T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M; Hashimoto K
    PLoS One; 2012; 7(8):e42676. PubMed ID: 22880079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.
    Karege F; Bondolfi G; Gervasoni N; Schwald M; Aubry JM; Bertschy G
    Biol Psychiatry; 2005 May; 57(9):1068-72. PubMed ID: 15860348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation.
    Giese M; Beck J; Brand S; Muheim F; Hemmeter U; Hatzinger M; Holsboer-Trachsler E; Eckert A
    J Psychiatr Res; 2014 Dec; 59():1-7. PubMed ID: 25258340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.
    Karlović D; Serretti A; Jevtović S; Vrkić N; Serić V; Peleš AM
    J Psychiatr Res; 2013 Feb; 47(2):162-7. PubMed ID: 23102630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.
    Haile CN; Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Foulkes A; Iqbal S; Mahoney JJ; De La Garza R; Charney DS; Newton TF; Mathew SJ
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):331-6. PubMed ID: 24103211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine.
    Ghosh R; Gupta R; Bhatia MS; Tripathi AK; Gupta LK
    Asian J Psychiatr; 2015 Dec; 18():37-41. PubMed ID: 26514447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced platelet BDNF level in patients with major depression.
    Lee BH; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):849-53. PubMed ID: 19371767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients.
    Dell'Osso L; Del Debbio A; Veltri A; Bianchi C; Roncaglia I; Carlini M; Massimetti G; Catena Dell'Osso M; Vizzaccaro C; Marazziti D; Piccinni A
    Neuropsychobiology; 2010; 62(4):207-12. PubMed ID: 20714169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression.
    Jevtović S; Karlović D; Mihaljević-Peleš A; Šerić V; Vrkić N; Jakšić N
    Psychiatr Danub; 2011 Dec; 23(4):363-9. PubMed ID: 22075737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder.
    Schröter K; Brum M; Brunkhorst-Kanaan N; Tole F; Ziegler C; Domschke K; Reif A; Kittel-Schneider S
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):169-181. PubMed ID: 30929061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
    Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.